Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
TSE:4502
Price:
4 069 JPY
-0.49%
Market Closed
Updated:
Apr 20, 2024
Takeda Pharmaceutical Co Ltd
Net Income (Common)
Last
Value
3-Years CAGR
5-Years CAGR
|
Takeda Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Comparables:
4568
4578
4523
4519
4503
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Income (Common)
¥178.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
2%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Income (Common)
¥186.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
23%
|
CAGR 10-Years
5%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Income (Common)
¥121.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
|
Eisai Co Ltd
TSE:4523
|
Net Income (Common)
¥45.4B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
1%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Income (Common)
¥325.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
20%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Net Income (Common)
¥37.3B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
See Also
What is Takeda Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
178.2B
JPY
178.2B
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Net Income (Common) amounts to 178.2B JPY.
What is Takeda Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
2%
2%
Over the last year, the Net Income (Common) growth was -35%.
You don't have any saved screeners yet
